NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases
- 18 April 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 6 (3) , 206-213
- https://doi.org/10.1002/ibd.3780060308
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- IKB kinase B(IKKB), but not NF-KB-inducing kinase (NIK) or IKKA, represents a therapeutic target for modulation of fas, IL-1B and TNFA-mediated NF-KB activation in intestinal epithelial cells (IEC)Gastroenterology, 2000
- Increased susceptibility to Fas-mediated apoptosis in differentiated HT-29 cells independent of its effects on NF-KB activation and IL-8 secretionGastroenterology, 2000
- Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated ConditionsMolecular and Cellular Biology, 2000
- Lineage-Restricted Function of Nuclear Factor κB–Inducing Kinase (Nik) in Transducing Signals via Cd40The Journal of Experimental Medicine, 2000
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Regulation of DNA binding by Rel/NF-κB transcription factors: structural viewsOncogene, 1999
- TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling ComplexImmunity, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- The IκB proteins: members of a multifunctional familyTrends in Genetics, 1993